Pharma Reviews: Veterans Unpacked | DS Brar: "Your network is your net worth, and your credibility is your currency"

D. "Davinder" S. Brar has been a pharmaceuticals industry veteran with a ... We opened the floodgates for the Indian pharma industry, which today ...
Read more: Veterans Unpacked | DS Brar: "Your network is your net worth, and your credibility is your currency"

Pharma Reviews: Top headlines: Sun Pharma's strong Q1 show, India-China military talks

Top headlines: Sun Pharma's strong Q1 show, India-China military talks ... Motors, told shareholders at the company's 76th annual general meeting.
Read more: Top headlines: Sun Pharma's strong Q1 show, India-China military talks

US FDA News: Coronavirus (COVID-19) Update: July 30, 2021

Coronavirus (COVID-19) Update: July 30, 2021
Read more: Coronavirus (COVID-19) Update: July 30, 2021

Pharma Reviews: Pharma PLI scheme can generate Rs 1.96 lakh crore export over 6 years: Union Health Minister

... the PLI scheme for the pharmaceutical industry to enhance India''s manufacturing capabilities by increasing investment and production in the sector.
Read more: Pharma PLI scheme can generate Rs 1.96 lakh crore export over 6 years: Union Health Minister

Pharma Reviews: Lupin acquires Australia's Southern Cross Pharma

Indian pharma major ... Southern Cross Pharma is a privately owned Australian company established in 2000 and provides pharmaceutical products ...
Read more: Lupin acquires Australia's Southern Cross Pharma

Pharma Reviews: Market LIVE Updates: Sensex, Nifty up over 0.16%; IT, auto, pharma top gainers

Indian indices were up over 0.16% on Friday. Asian markets opened lower with Japanese indices witnessing the biggest weekly foreign money ...
Read more: Market LIVE Updates: Sensex, Nifty up over 0.16%; IT, auto, pharma top gainers

US FDA News: False Positive Results with BD SARS-CoV-2 Reagents for the BD Max System - Letter to Clinical Laboratory Staff and Health Care Providers

FDA warns lab staff that use of BD SARS-CoV-2 Reagents for the BD Max System may lead to false positive results.
Read more: False Positive Results with BD SARS-CoV-2 Reagents for the BD Max System - Letter to Clinical Laboratory Staff and Health Care Providers

US FDA News: Philips Respironics CPAP, BiPAP, and Ventilator Recall: Frequently Asked Questions

Find answers to frequently asked questions on Philips Respironics ventilators, BiPAP, and CPAP machines recall
Read more: Philips Respironics CPAP, BiPAP, and Ventilator Recall: Frequently Asked Questions

Pharma Reviews: Market HIGHLIGHTS: Sensex snaps 3-day losing run, Nifty above 15750 on F&O expiry, bulls take ...

Indian stock market set to snap 3-day losing streak on F&O expiry day ... Tatva Chintan Pharma 2nd company in green chemical space to get listed.
Read more: Market HIGHLIGHTS: Sensex snaps 3-day losing run, Nifty above 15750 on F&O expiry, bulls take ...

US FDA News: FDA Approves First Interchangeable Biosimilar Insulin Product for Treatment of Diabetes

FDA Approves First Interchangeable Biosimilar Insulin Product for Treatment of Diabetes; Availability Will Help Increase Access and Potentially Lower the Cost of Insulin for People with Diabetes
Read more: FDA Approves First Interchangeable Biosimilar Insulin Product for Treatment of Diabetes

US FDA News: FDA In Brief: FDA Warns Firm with Over 15 Million Products Listed with FDA to Remove Unauthorized E-Cigarette Products from Market

FDA issued a warning letter to Visible Vapors LLC advising that marketing its tobacco products without premarket authorization, is illegal, and they can’t be sold or distributed in the U.S.
Read more: FDA In Brief: FDA Warns Firm with Over 15 Million Products Listed with FDA to Remove Unauthorized E-Cigarette Products from Market

Pharma Reviews: Pharma PLI scheme has export generation potential of Rs 1.96 lakh cr over 6 yrs: Mandaviya

... the PLI scheme for the pharmaceutical industry to enhance India's manufacturing capabilities by increasing investment and production in the sector.
Read more: Pharma PLI scheme has export generation potential of Rs 1.96 lakh cr over 6 yrs: Mandaviya

Pharma Reviews: Closing Bell: Sensex falls 135 pts, Nifty holds 15700; financials drag, metals shine

The pharma company on July 27 reported a 2.8 percent year-on-year (YoY) rise in Q1FY22 net profit at Rs 330 crore, helped by India formulation, ...
Read more: Closing Bell: Sensex falls 135 pts, Nifty holds 15700; financials drag, metals shine

Pharma Reviews: Market LIVE Updates: Sensex, Nifty down over 0.40%; metals gain; banks drag

BAL is getting positive momentum in stock due to the company increasing tariffs rate for the postpaid subscriber. ... Sanofi India sells nutraceuticals biz to Kedaara-Universal Medicare for ₹587 cr ... Pharma stocks top drags. Nifty top ...
Read more: Market LIVE Updates: Sensex, Nifty down over 0.40%; metals gain; banks drag

Pharma Reviews: Torrent Pharma gains 3% in a weak market on healthy margins in June quarter

As per All Indian Origin Chemists & Distributors (AIOCD) data, Torrent's Q1FY22 growth was 24 per cent versus Indian Pharmaceutical Market (IPM) ...
Read more: Torrent Pharma gains 3% in a weak market on healthy margins in June quarter

Pharma Reviews: India among top 10 countries in pharma, healthcare: Report

India is among the top 10 countries in pharma and healthcare sector with exponential growth recorded in the last five years, according to a report by ...
Read more: India among top 10 countries in pharma, healthcare: Report

Pharma Reviews: Emcure Pharma strengthens its board; adding Independent Directors

New Delhi, July 27th 2021: Emcure Pharmaceuticals Ltd., one of India's leading pharma players continues to strengthen its leadership with ...
Read more: Emcure Pharma strengthens its board; adding Independent Directors

Pharma Reviews: Emcure strengthens board by including 4 new independent directors

The drug firm aims to further augment its strengths as one of the fastest growing pharmaceutical companies in India with a global reach of over 70 ...
Read more: Emcure strengthens board by including 4 new independent directors

Pharma Reviews: Emcure Pharma rejig its board, likely to file DRHP next week for Rs 4000 crore IPO

Mumbai: Pune-based Emcure Pharmaceuticals, one of India's biggest unlisted pharma companies likely to file its draft red herring prospectus (DRHP) ...
Read more: Emcure Pharma rejig its board, likely to file DRHP next week for Rs 4000 crore IPO

Pharma Reviews: India-made Sputnik V vax to be available during Sept-Oct: Dr Reddy's

Hyderabad: Hyderabad-based pharmaceuticals company Dr Reddy's Laboratories said on Tuesday that the locally manufactured Covid-19 Sputnik V ...
Read more: India-made Sputnik V vax to be available during Sept-Oct: Dr Reddy's

Pharma Reviews: Glenmark Life Sciences IPO: Company Aims to Raise Funds Amidst a Pharma Sell-Off

Since FY 2018, the Indian API market has grown at a steady rate of 9.2%, and it is expected to continue to grow as the global pharmaceutical industry ...
Read more: Glenmark Life Sciences IPO: Company Aims to Raise Funds Amidst a Pharma Sell-Off

Pharma Reviews: Market Movers: Why Dr Reddy's fell & took other drug stocks down with it

jumped nearly 6 per cent today after the Indian Express reported that Jeff Bezos' Amazon is contemplating an acquisition of the media distributors, ...
Read more: Market Movers: Why Dr Reddy's fell & took other drug stocks down with it

Pharma Reviews: Back to old normal: Pharma industry returns to pre-pandemic growth level

India's Rs 1.5-trillion domestic pharmaceuticals market is largely normalised and back on the growth path, though volume growth remains a cause for ...
Read more: Back to old normal: Pharma industry returns to pre-pandemic growth level

Pharma Reviews: Despite import alert for India plant, Jubilant Pharma rating headroom healthy: Fitch

... for its generic formulations plant in India will be limited, Fitch Ratings has said. JPL has fewer production facilities than larger pharmaceutical peers ...
Read more: Despite import alert for India plant, Jubilant Pharma rating headroom healthy: Fitch

Pharma Reviews: Nifty Pharma index slips 5%, records sharpest intra-day fall in 7 months

The acute and specialty segments grew faster than the represented pharmaceutical market, the company said. "India business grew exceptionally well ...
Read more: Nifty Pharma index slips 5%, records sharpest intra-day fall in 7 months

Pharma Reviews: DCGI directs pharma companies to submit information of pre-1988 permitted FDCs on their safety ...

The DCGI notice on FDCs has been sent to the Indian Drug and Pharmaceuticals Associations and also uploaded on the website of CDSCO for ...
Read more: DCGI directs pharma companies to submit information of pre-1988 permitted FDCs on their safety ...

Pharma Reviews: Nifty Pharma in a steep nosedive, index dips 430 pts as Dr Reddy's slump 8% after Q1; Aurobindo ...

Nifty Pharma index has slipped to at least nearly 435 points with an intraday low of 14,246.15. Jul 27, 2021 12:07 IST | India Infoline News Service. A ⁺ ...
Read more: Nifty Pharma in a steep nosedive, index dips 430 pts as Dr Reddy's slump 8% after Q1; Aurobindo ...

Pharma Reviews: Your ₹20000 would have become ₹1 crore in this pharma stock in 18 years

The pharma stock is one of the multi-bagger stocks in India as it has ... buy Divis Lab shares at current market price for the target of ₹5000 maintaining ...
Read more: Your ₹20000 would have become ₹1 crore in this pharma stock in 18 years

Pharma Reviews: Closing Bell: Nifty ends below 15750, Sensex falls 273 pts on weak Asian market cues

Taking Stock: Indian Indices Fall On Weak Asian Cues; Pharma Worst Hit ... Ajit Mishra, VP - Research, Religare Broking: Markets traded volatile for yet ...
Read more: Closing Bell: Nifty ends below 15750, Sensex falls 273 pts on weak Asian market cues

Pharma Reviews: GSK Pharma gives 2 brands' rights to Asia co

Our pharmaceutical manufacturing team worked round the clock to fulfil significantly increased demand for our key brands, especially for Calpol ( ...
Read more: GSK Pharma gives 2 brands' rights to Asia co

Pharma Reviews: Tatva Chintan Pharma Chem IPO share allotment status: Here's how to check your shares

Tatva Chintan Pharma Chem IPO share allotment status: Here's how to ... The IPO of the Vadodara-based specialty chemical manufacturing firm has a ... is Link Intime India (Click here: https://ift.tt/3vKu4no).
Read more: Tatva Chintan Pharma Chem IPO share allotment status: Here's how to check your shares

Pharma Reviews: Pharma PLI scheme has export generation potential of Rs 1.96 tn: Mandaviya

The production linked incentive scheme (PLI) for pharmaceutical products has ... The government had approved the PLI scheme for pharmaceuticals on ... low-value generic drugs account for the major component of Indian exports.
Read more: Pharma PLI scheme has export generation potential of Rs 1.96 tn: Mandaviya

Pharma Reviews: Population populism: UP has no option left but to control its population

India has also seen forced sterilisation being used a measure to control ... The pharmaceutical industry wants the government to provide them ...
Read more: Population populism: UP has no option left but to control its population

Pharma Reviews: India among top 10 countries in pharma, healthcare: Sagacious IP Report

... by Indian companies and MNCs with research centres based in India. The pharma and healthcare sector has also seen massive growth in global ...
Read more: India among top 10 countries in pharma, healthcare: Sagacious IP Report

Pharma Reviews: India among top 10 countries in pharma, healthcare: Report

The top Indian filers who filed patents in India during the last five years (2015-2020) include the Council of Scientific and Industrial Research (CSIR), ITC ...
Read more: India among top 10 countries in pharma, healthcare: Report

Pharma Reviews: Glenmark Life Sciences IPO opens Today; grey market premium at 20%, should you subscribe?

A subsidiary of Glenmark Pharmaceuticals, Glenmark Life Sciences is a ... “Indian API players could benefit as Chinese manufacturers battle strict ...
Read more: Glenmark Life Sciences IPO opens Today; grey market premium at 20%, should you subscribe?

Pharma Reviews: Covid-19: BDR Pharma inks agreement with DRDO for production of 2-DG

... India. The pharmaceutical company will work with the Institute of Nuclear ... The DRDO recently signed agreements with four major Indian medicine ...
Read more: Covid-19: BDR Pharma inks agreement with DRDO for production of 2-DG

Pharma Reviews: Day trading guide for Monday: 5 stocks to buy or sell today — July 26

5] Sun Pharmaceutical Industries or Sun Pharma: Buy at ₹CMP, target ₹715, stop loss ₹685. Disclaimer: The views and recommendations made ...
Read more: Day trading guide for Monday: 5 stocks to buy or sell today — July 26

Pharma Reviews: Vijay Mallya declared bankrupt by London High Court

Also Read: Indian pharma industry to touch USD 130 bn by 2030: Reddy ... The 65-year-old businessman, wanted in India on fraud and money ...
Read more: Vijay Mallya declared bankrupt by London High Court

Pharma Reviews: Used-car market to more than double to 8.2 mn units by FY'26: Report

The used-car market was 4.4 million units worth USD 19 billion in the ... Also Read: Indian pharma industry to touch USD 130 bn by 2030: Reddy ...
Read more: Used-car market to more than double to 8.2 mn units by FY'26: Report

Pharma Reviews: India among top 10 countries in pharma, healthcare: Report

The pharma and ...
Read more: India among top 10 countries in pharma, healthcare: Report

Pharma Reviews: What is in the COVID portfolio of top pharma companies? | Nithya Balasubramanian to ET Now

... Pharma and healthcare Analyst at Sanford Bernstein joins in to discuss the second wave of the coronavirus outbreak in India and how it has affected ...
Read more: What is in the COVID portfolio of top pharma companies? | Nithya Balasubramanian to ET Now

Pharma Reviews: India among top 10 countries in pharma, healthcare: Report

New Delhi, July 26 India is among the top 10 countries in pharma and healthcare sector with exponential growth recorded in the last five years, ...
Read more: India among top 10 countries in pharma, healthcare: Report

Pharma Reviews: BDR Pharma, DRDO collaborate for COVID drug 2-DG production

Last month, the Drugs Controller General of India (DCGI) had approved the ... and market COVID-19 drug 2-Deoxy-D-Glucose (2-DG) in the country.
Read more: BDR Pharma, DRDO collaborate for COVID drug 2-DG production

Pharma Reviews: Sai Life Sciences Wins Golden Peacock National Training Award 2021

HYDERABAD, India, July 26, 2021 /PRNewswire/ -- Sai Life Sciences, one of ... This is the second consecutive Golden Peacock Award for the company ... Today, it works with 7 of the top 10 large pharma companies, as well as ...
Read more: Sai Life Sciences Wins Golden Peacock National Training Award 2021

Pharma Reviews: HC restrains Natco Pharma from manufacturing, using insecticides with FMC Corporation's patent

NEW DELHI: The Delhi high court has restrained an Indian generic drug maker from manufacturing and using any insecticide that contains a key ...
Read more: HC restrains Natco Pharma from manufacturing, using insecticides with FMC Corporation's patent

Pharma Reviews: Indian pharma industry to touch USD 130 billion by 2030: Dr Reddys Chief

Hyderabad: The Indian pharmaceutical industry is expected to grow almost by three times to about 130 billion US dollars by 2030, Chairman of Dr ...
Read more: Indian pharma industry to touch USD 130 billion by 2030: Dr Reddys Chief

Pharma Reviews: Markets LIVE Updates: Sensex, Nifty flat; auto, PSU banks drag; metals gain

Benchmark Indian equity indices gained 0.15% after opening flat on ... Pharma, SBI Life Insurance, Kotak Mahindra Bank, among other companies will ...
Read more: Markets LIVE Updates: Sensex, Nifty flat; auto, PSU banks drag; metals gain

Pharma Reviews: PEs look to buy into Integrace, True North may sell 30% stake

Creador has investments in Indian pharma companies such as Paras ... is also an active investor in the healthcare & pharmaceuticals industry in India, ...
Read more: PEs look to buy into Integrace, True North may sell 30% stake

Pharma Reviews: Covaxin stares at an uncertain launch in US amid a class-action lawsuit

In February, the company announced that it was tying up with Bharat ... filings also threaten the Indian pharma industry's ability to launch a vaccine in a ...
Read more: Covaxin stares at an uncertain launch in US amid a class-action lawsuit

Pharma Reviews: Revolt Motor to launch low-priced e-bike model from early next year

The manufacturing of the new bike will start from January, she said. ... Also Read: Indian pharma industry to touch USD 130 bn by 2030: Reddy ...
Read more: Revolt Motor to launch low-priced e-bike model from early next year

Pharma Reviews: Indian pharma industry to touch USD 130 bn by 2030: Reddy

The Indian pharmaceutical sector can contribute to the country through the development of drugs for India-specific ailments which, unfortunately, ...
Read more: Indian pharma industry to touch USD 130 bn by 2030: Reddy

Pharma Reviews: Pharma an alluring career option now

Indian pharmaceutical industry is one of the largest pharma industries in the world and this widens the scope of Pharma studies in India and abroad. As ...
Read more: Pharma an alluring career option now

Pharma Reviews: Indian pharma industry to touch $130 bn by 2030: Dr Reddy's chairman

The Indian pharmaceutical industry is expected to grow almost by three times to about 130 billion US dollars by 2030, Chairman of Dr Reddy's ...
Read more: Indian pharma industry to touch $130 bn by 2030: Dr Reddy's chairman

Pharma Reviews: Workers Against Privatisation of Bengal Chemicals, India's First Pharma Concern

Kolkata, August 23: Workers and employees of the PSU Bengal Chemicals and Pharmaceuticals Ltd (BCPL) – India's first pharmaceutical company ...
Read more: Workers Against Privatisation of Bengal Chemicals, India's First Pharma Concern

US FDA News: Coronavirus (COVID-19) Update: July 23, 2021

Coronavirus (COVID-19) Update: July 23, 2021
Read more: Coronavirus (COVID-19) Update: July 23, 2021

Pharma Reviews: Torrent Pharma shares up 1.72% as Nifty gains

Torrent Pharmaceuticals Ltd. belongs to the Pharma - Indian industry. Read More News on. torrent pharma share priceTorrent PharmanseBSEsensex ...
Read more: Torrent Pharma shares up 1.72% as Nifty gains

Pharma Reviews: 2 Stocks in Pharma and Fertilizer Sector to Consider

Pharmaceutical and chemical sector stocks continue to do well. ... Gujarat, Cadila Healthcare is an Indian multinational pharmaceutical company.
Read more: 2 Stocks in Pharma and Fertilizer Sector to Consider

Pharma Reviews: Inter-ministerial talks on to finalise ecommerce policy: Govt to Parliament

Some imports like Active Pharmaceutical Ingredients (APIs) and drug formulations, sold at very competitive rates, provide the Indian Pharma industry ...
Read more: Inter-ministerial talks on to finalise ecommerce policy: Govt to Parliament

Pharma Reviews: Glenmark Life Sciences IPO - Why It May Not Be the Best Buy

Glenmark Pharmaceuticals, the parent company (and promoter) of Glenmark Life, is one of the top pharma companies in India. Established in 1977 ...
Read more: Glenmark Life Sciences IPO - Why It May Not Be the Best Buy

Pharma Reviews: India's illicit drug trade is being fuelled by prescription drugs and controlled chemicals

Prescription drugs and their ingredients, or “precursors”, are being increasingly diverted for recreational use in India – the largest manufacturer of ...
Read more: India's illicit drug trade is being fuelled by prescription drugs and controlled chemicals

Pharma Reviews: Covid 19 Pandemic: A Blessing In Disguise For Startups

The Indian startup ecosystem has been prospering despite the pandemic ... Indian Pharma, Device and Diagnostic Companies and MediSage has ...
Read more: Covid 19 Pandemic: A Blessing In Disguise For Startups

Pharma Reviews: Dubai - The Next Healthcare And Pharma Hub

Dubai is keen on attracting pharmaceutical companies from India reflects in the words of Humaid Al Qutami, Director General of Dubai Health Authority ...
Read more: Dubai - The Next Healthcare And Pharma Hub

Pharma Reviews: Five institutions come together to organise virtual workshops series on GMP

In her inaugural address, Aparna said, “These workshops have reinforced and enhanced the capacity and abilities of the Indian pharmaceutical sector, ...
Read more: Five institutions come together to organise virtual workshops series on GMP

Pharma Reviews: Gland Pharma share price at record high, zooms 177% from IPO price in 8 months; what's fueling ...

Gland Pharma's Rs 6,480-crore IPO, India's biggest pharma public issue, ... The company's core market has reported a 16 per cent on-year revenue ...
Read more: Gland Pharma share price at record high, zooms 177% from IPO price in 8 months; what's fueling ...

Pharma Reviews: Prices of oral diabetes drugs set to fall as patents near expiry date

Sun Pharmaceuticals has acquired the patent license to manufacture and commercialise dapagliflozin and dapagliflozin metformin combination in India ...
Read more: Prices of oral diabetes drugs set to fall as patents near expiry date

Pharma Reviews: Granules India arm clears USFDA audit

Hyderabad: Granules India Limited has announced that Granules Pharmaceuticals, Inc. (GPI), a wholly owned foreign subsidiary of the Company ...
Read more: Granules India arm clears USFDA audit

Pharma Reviews: Intas Enters into an Exclusive License Agreement with Meiji and Dong-A ST to commercialize DMB ...

AHMEDABAD, India, July 22, 2021 /PRNewswire/ --Intas Pharmaceuticals ... Meiji is a leading pharmaceutical company in Japan in the therapeutic ...
Read more: Intas Enters into an Exclusive License Agreement with Meiji and Dong-A ST to commercialize DMB ...

Pharma Reviews: Zomato listing tomorrow on BSE, NSE after bumper IPO; Nifty holds above 15800 today, Sensex ...

Share Market News Today | Zomato shares will list on BSE and NSE ... Gland Pharma's Rs 6,480-crore IPO, India's biggest pharma public issue, was ...
Read more: Zomato listing tomorrow on BSE, NSE after bumper IPO; Nifty holds above 15800 today, Sensex ...

US FDA News: Philips Respironics Recalls Certain Continuous and Non-Continuous Ventilators, including CPAP and BiPAP, Due to Risk of Exposure to Debris and Chemicals

The Continuous and Non-Continuous Ventilators are used to provide invasive and non-invasive support for people needing respiratory support or treatment for sleep disorders
Read more: Philips Respironics Recalls Certain Continuous and Non-Continuous Ventilators, including CPAP and BiPAP, Due to Risk of Exposure to Debris and Chemicals

US FDA News: Philips Respironics Recalls Certain Ventilators and BiPAP Machines Due to Potential Health Risks from PE-PUR Sound Abatement Foam

PE-PUR sound abatement foam in certain Philips Respironics ventilators and BiPAP machines may pose health risks
Read more: Philips Respironics Recalls Certain Ventilators and BiPAP Machines Due to Potential Health Risks from PE-PUR Sound Abatement Foam

Pharma Reviews: Prescription drugs, controlled chemicals fuel illicit drug trade in India

India's pharmaceutical industry is "the largest provider of generic drugs globally", as per the department of pharmaceuticals, Ministry of Chemicals and ...
Read more: Prescription drugs, controlled chemicals fuel illicit drug trade in India

Pharma Reviews: Prescription Drugs, Controlled Chemicals Are Fuelling India's Illicit Drug Trade: Reports

But tramadol is only one of India's growing drug problems. ... India's pharmaceutical industry is "the largest provider of generic drugs globally", as per ...
Read more: Prescription Drugs, Controlled Chemicals Are Fuelling India's Illicit Drug Trade: Reports

US FDA News: Vero Biotech Recalls GENOSYL DS; Nitric Oxide Delivery System Due to Software Error

The GENOSYL DS; Nitric Oxide Delivery System delivers GENOSYL (Nitric Oxide) to newborns with respiratory failure.
Read more: Vero Biotech Recalls GENOSYL DS; Nitric Oxide Delivery System Due to Software Error

Pharma Reviews: Should You Apply for Glenmark Life Sciences IPO?

Indian pharmaceutical industry. Around two years ago, we published an article on the Indian Pharmaceutical industry confirming our positive bias in ...
Read more: Should You Apply for Glenmark Life Sciences IPO?

Pharma Reviews: Hyderabad firms dominate bulk drugs sector

Statistics show that five of the top 10 pharma companies in India that ... B&K Securities projects that the Indian bulk drugs industry will more than ...
Read more: Hyderabad firms dominate bulk drugs sector

Pharma Reviews: Zydus Cadila gets tentative nod from USFDA to market cancer drug

'Recovery on, India's GDP on course for 7% yearly growth' ... In a panel discussion as part of TOI's A Shot of Hope' campaign, health experts and ...
Read more: Zydus Cadila gets tentative nod from USFDA to market cancer drug

Pharma Reviews: Pharma GMP workshops to enhance production of high-quality APIs: Secretary, DoP

The workshop addresses the vital importance of strengthening the capacities of Indian pharma manufacturing facilities to meet the current GMP and ...
Read more: Pharma GMP workshops to enhance production of high-quality APIs: Secretary, DoP

Pharma Reviews: Glenmark Life Sciences Limited IPO price brand at ₹695 to ₹720 per share

... sale of up to 6,300,000 equity shares by Glenmark Pharmaceuticals Limited. The company and the promoter selling shareholder may, in consultation ... Kotak Mahindra Capital Company Limited, BofA Securities India Limited and ...
Read more: Glenmark Life Sciences Limited IPO price brand at ₹695 to ₹720 per share

US FDA News: Coronavirus (COVID-19) Update: July 20, 2021

Coronavirus (COVID-19) Update: July 20, 2021
Read more: Coronavirus (COVID-19) Update: July 20, 2021

Pharma Reviews: 'Talent demand rises 11% in June; healthcare, pharma lead'

'Talent demand rises 11% in June; healthcare, pharma lead' ... cent rise in demand especially when the third Covid wave is expected to hit India by August. The healthcare/pharmaceutical sector recorded a maximum monthly growth ...
Read more: 'Talent demand rises 11% in June; healthcare, pharma lead'

Pharma Reviews: Piramal Enterprises better positioned to finalise demerger plan of firms in Financial Services and ...

Piramal Enterprises better positioned to finalise demerger plan of firms in Financial Services and Pharma sector post DHFL acquisition. Piramal said, " ...
Read more: Piramal Enterprises better positioned to finalise demerger plan of firms in Financial Services and ...

Pharma Reviews: Pharma sector Q1FY22 preview: Strong growth seen in India biz; US sales likely to remain flat

The Indian pharma market witnessed a growth of 37.2 percent in value terms for Q1FY22, partly aided by the COVID-19 portfolio. Meanwhile, these ...
Read more: Pharma sector Q1FY22 preview: Strong growth seen in India biz; US sales likely to remain flat

Pharma Reviews: Glenmark's debt reduction, IPO for life sciences arm may trigger re-rating

The company has seen about 105% growth during the quarter, as per Indian Pharma Market data. Hence, one may expect strong domestic sales ...
Read more: Glenmark's debt reduction, IPO for life sciences arm may trigger re-rating

Pharma Reviews: Pharma sector's earnings to be fired by dual engines during Q1

The Indian pharma market (IPM) had grown 37% y-o-y and 15% sequentially in Q1. The growth was driven by sales of covid treatment drugs and other ...
Read more: Pharma sector's earnings to be fired by dual engines during Q1

US FDA News: Statins: Drug Safety Communication - FDA Requests Removal of Strongest Warning Against Using Cholesterol-lowering Statins During Pregnancy

FDA is requesting removal of its strongest warning against using cholesterol-lowering statin medicines in pregnant patients.
Read more: Statins: Drug Safety Communication - FDA Requests Removal of Strongest Warning Against Using Cholesterol-lowering Statins During Pregnancy

Pharma Reviews: Market LIVE Updates: Indices near day's low with Nifty around 15600; metals, financials drag

CLSA has maintained outperform rating on Nippon Life India Asset ... of performing sectors with earnings visibility like IT, pharma, metals, cement, ...
Read more: Market LIVE Updates: Indices near day's low with Nifty around 15600; metals, financials drag

Pharma Reviews: Market Highlights: Sensex tanks 586 pts on closing, Nifty ends at 15752; HDFC Bank, IndusInd ...

Bank Nifty ended 1.88% lower while India VIX ended 8% higher. ... The initial public offer (IPO) of Tatava Chintan Pharma continued to attract investors ...
Read more: Market Highlights: Sensex tanks 586 pts on closing, Nifty ends at 15752; HDFC Bank, IndusInd ...

Pharma Reviews: DAILY VOICE | Pharma, IT among 6 sectors that will create multibaggers this decade: Amit Jain of ...

Q: What are the biggest risks for Indian equity markets right now? The biggest risk for the global & Indian stock market is the reversal of the lower interest ...
Read more: DAILY VOICE | Pharma, IT among 6 sectors that will create multibaggers this decade: Amit Jain of ...

Pharma Reviews: ICMR, public face of India's Covid response, comes under fire for decisions

For a century, the Indian Council of Medical Research was a little known ... up benefiting the pharmaceutical industry rather than patients, critics say.
Read more: ICMR, public face of India's Covid response, comes under fire for decisions

Pharma Reviews: Costs of raw material for drugs rise by up to 140%

There have also been massive increases in freight rates, transportation and packaging costs,” Indian Drug Manufacturers' Association ED Ashok ...
Read more: Costs of raw material for drugs rise by up to 140%

US FDA News: Pfizer Issues a Voluntary Nationwide Recall for Twelve Lots of CHANTIX® (Varenicline) Tablets Due to N-Nitroso Varenicline Content

Pfizer is voluntarily recalling two lots of Chantix 0.5mg Tablets, two lots of Chantix 1 mg Tablets, and eight lots of a Chantix kit of 0.5mg/1 mg Tablets to the patient (consumer/user) level due to the presence of a nitrosamine, N-nitroso-varenicline, above the Pfizer established Acceptable Daily I
Read more: Pfizer Issues a Voluntary Nationwide Recall for Twelve Lots of CHANTIX® (Varenicline) Tablets Due to N-Nitroso Varenicline Content

Pharma Reviews: Digital transformation: Pharma's pivot for post-pandemic success

India's pharmaceutical industry is estimated to reach $65 billion by 2024, ... One of the key strategic priorities for the pharma industry, including R&D, ...
Read more: Digital transformation: Pharma's pivot for post-pandemic success

Pharma Reviews: Stock Market Live Updates: Sensex, Nifty trade over a percent lower; Nifty Bank down over 800 points

Stock Market Live Updates: Indian equity indices, Sensex and Nifty are ... financial services, IT and auto indices, while buying Nifty Pharma and Realty.
Read more: Stock Market Live Updates: Sensex, Nifty trade over a percent lower; Nifty Bank down over 800 points

Pharma Reviews: Market Live Updates | Indices trade in the red dragged by HDFC twins; GR Infra, Clean Science ...

NTPC, BPCL and Indian Oil Corporation are the top gainers while HDFC twins, ... trading in the red while pharma and energy sectors are trading in the green. ... has reflected in the decline in crude prices is a macro positive for India.
Read more: Market Live Updates | Indices trade in the red dragged by HDFC twins; GR Infra, Clean Science ...

Pharma Reviews: Market LIVE Updates: Sensex down over 350 pts, Nifty above 15800; pharma gains

Stock Market LIVE Updates: Indian indices were down over 0.64% on Monday. At 9:59 am, the Sensex was at 52,771.36, down 368.7 points, or 0.69%, ...
Read more: Market LIVE Updates: Sensex down over 350 pts, Nifty above 15800; pharma gains

Pharma Reviews: Universal Medicare-Kedaara Capital consortium emerges as the frontrunner to acquire Sanofi ...

... to acquire the same portfolio from the French pharma giant's Indian arm, multiple industry sources with knowledge of the matter told Moneycontrol.
Read more: Universal Medicare-Kedaara Capital consortium emerges as the frontrunner to acquire Sanofi ...

Pharma Reviews: Tatva Chintan Pharma IPO subscribed 4.51 times on first day of subscription

The Vadodara-based firm is a specialty chemical manufacturing company. The company export most of its products to over 25 countries, including the ...
Read more: Tatva Chintan Pharma IPO subscribed 4.51 times on first day of subscription

Pharma Reviews: India Needs To Diversify Pharma Raw Material Imports, Up R&D Spends: RBI Paper

India is the third largest pharma manufacturer in the world by volume and fourteenth by value and the sector contributes 2 per cent of Indian GDP and ...
Read more: India Needs To Diversify Pharma Raw Material Imports, Up R&D Spends: RBI Paper

Pharma Reviews: Market HIGHLIGHTS: Sensex ends flat, Nifty above 15900, after hitting record highs in intraday ...

In 2010 Coal India IPO was the biggest IPO in India with IPO size of Rs 15200 ... Tatva Chintan Pharma IPO opens; firm raises Rs 150 cr from anchor ...
Read more: Market HIGHLIGHTS: Sensex ends flat, Nifty above 15900, after hitting record highs in intraday ...

US FDA News: Coronavirus (COVID-19) Update: July 16, 2021

Coronavirus (COVID-19) Update
Read more: Coronavirus (COVID-19) Update: July 16, 2021

Pharma Reviews: RBI bulletin calls for diversification of pharma raw material imports, increasing pharma R&D spends

The COVID-19 pandemic has been a “stress test” for the Indian pharma industry, and exposed its high dependence on imported raw materials and ...
Read more: RBI bulletin calls for diversification of pharma raw material imports, increasing pharma R&D spends

Pharma Reviews: India needs to diversify pharma raw material imports, up R&D spends: RBI paper

India is the third largest pharma manufacturer in the world by volume and fourteenth by value, and the sector contributes 2 per cent of Indian GDP and 8 ...
Read more: India needs to diversify pharma raw material imports, up R&D spends: RBI paper

Pharma Reviews: No application received for EU authorisation of Covishield, says European Medicines Agency

New Delhi: The European Medicines Agency (EMA) said it has not received any ... (EMA) for its COVID-19 vaccine Covishield in a month, the company's CEO Adar ... Speaking at India Global Forum 2021, Poonawalla said, "It is not a ...
Read more: No application received for EU authorisation of Covishield, says European Medicines Agency

Pharma Reviews: Market LIVE Updates: Sensex slips 50 pts, Nifty at 15900; pharma top gainer

Indian indices opened at record highs on Friday driven by surge in realty stocks. Asian stocks dipped Friday amid concerns about the economic ...
Read more: Market LIVE Updates: Sensex slips 50 pts, Nifty at 15900; pharma top gainer

Pharma Reviews: Building unicorns in pharma API space to make India Atma Nirbhar

REUTERS/Bryan Woolston/File Photo Indian market context. API as a sector has been a neglected space within the Indian pharma, with India's share ...
Read more: Building unicorns in pharma API space to make India Atma Nirbhar

Pharma Reviews: Stock Market Live Updates: Sensex off day's high, Nifty holds 15900; pharma gains, IT drags

Stock Market Live Updates: Indian indices fell from record-high levels to trade flat as losses in IT and banks offset gains in pharma, metals and FMCG ...
Read more: Stock Market Live Updates: Sensex off day's high, Nifty holds 15900; pharma gains, IT drags

Pharma Reviews: Venus Remedies launches consumer healthcare division

Drug firm Venus Remedies on Thursday said it has launched a consumer healthcare division that will offer a variety of products in segments like ...
Read more: Venus Remedies launches consumer healthcare division

Pharma Reviews: India needs to diversify pharma raw material imports, up R&D spends: RBI paper

"The high import dependency and surprisingly low R&D intensity of exports in the Indian pharmaceutical sector call for timely diversification of source ...
Read more: India needs to diversify pharma raw material imports, up R&D spends: RBI paper

Pharma Reviews: Big Pharma's COVID-19 reputation boost may not last — here's why

REUTERS/Dado Ruvic/Illustration The race for developing effective COVID-19 vaccines has put the pharmaceutical industry in the spotlight. Over the ...
Read more: Big Pharma's COVID-19 reputation boost may not last — here's why

US FDA News: FDA Grants First Full Approval for Treatment of Lymphoma in Dogs

The FDA fully approved a drug intended to treat lymphoma in dogs, making the drug the first conditionally approved new animal drug for dogs to achieve full FDA approval.
Read more: FDA Grants First Full Approval for Treatment of Lymphoma in Dogs

US FDA News: Potential Concerns with NuVasive MAGEC System Implants - FDA Safety Communication

Potential concerns in MAGEC system implants may include endcap separation and need for additional biocompatibility testing.
Read more: Potential Concerns with NuVasive MAGEC System Implants - FDA Safety Communication

Pharma Reviews: Big Pharma's COVID-19 reputation boost may not last — here's why

Prior to the COVID-19 pandemic, the pharmaceutical industry had been battling reputational damage for years. Notably, it sank to the bottom of Gallup's ...
Read more: Big Pharma's COVID-19 reputation boost may not last — here's why

Pharma Reviews: Sanjay Verma joins Akums India as Group CIO

Akums is among the re-known contract manufacturing pharmaceutical (CMRP) companies in India and holds 11- 12% shares of the overall drugs ...
Read more: Sanjay Verma joins Akums India as Group CIO

US FDA News: Risk of False Results with the Curative SARS-Cov-2 Test for COVID-19: FDA Safety Communication

This Safety Communication describes the risk of false results, particularly false negative results, with the Curative SARS-Cov-2 test. Recommendations for patients, caregivers and health care professionals are provided.
Read more: Risk of False Results with the Curative SARS-Cov-2 Test for COVID-19: FDA Safety Communication

Pharma Reviews: Market LIVE Updates: Sensex, Nifty at record highs; IT, metals, realty gain

Aviation ministry issues draft rules to ensure ease of using drones in India ... Tech up by 4.72% while banking and pharma sectors are consolidating.
Read more: Market LIVE Updates: Sensex, Nifty at record highs; IT, metals, realty gain

Pharma Reviews: Coronavirus News LIVE Updates: Pfizer, Johnson & Johnson yet to apply for license of COVID-19 ...

The Indian government is in talks with pharma majors such as Pfizer, ... COVID-19 vaccines has put the pharmaceutical industry in the spotlight.
Read more: Coronavirus News LIVE Updates: Pfizer, Johnson & Johnson yet to apply for license of COVID-19 ...

Pharma Reviews: Manufacturing cooperation is key to equitable access of vaccines across countries: Dr. Rajesh Jain ...

The Indian pharma companies along with the government are continuously ... How is Indian industry contributing towards vaccine production and ...
Read more: Manufacturing cooperation is key to equitable access of vaccines across countries: Dr. Rajesh Jain ...

US FDA News: Johnson & Johnson Consumer Inc. Issues Voluntary Recall of Specific NEUTROGENA® and AVEENO® Aerosol Sunscreen Products Due to the Presence of Benzene

Johnson & Johnson Consumer Inc. (JJCI) is voluntarily recalling all lots of five NEUTROGENA® and AVEENO® aerosol sunscreen product lines to the consumer level. Internal testing identified low levels of benzene in some samples of the products. Consumers should stop using the affected products and fol
Read more: Johnson & Johnson Consumer Inc. Issues Voluntary Recall of Specific NEUTROGENA® and AVEENO® Aerosol Sunscreen Products Due to the Presence of Benzene

Pharma Reviews: Stock Market Highlights: Sensex gains 134 points, Nifty ends above 15850 led by IT, pharma stocks

Stock Market Highlights: Indian equity indices, Sensex and Nifty ended higher Wednesday led by strong gains in IT and pharma stocks. Midcap and ...
Read more: Stock Market Highlights: Sensex gains 134 points, Nifty ends above 15850 led by IT, pharma stocks

Pharma Reviews: API is a decadal Opportunity for Indian Pharma Sector: Sudarshan Jain, Apax Partners

Sudharshan Jain speaks to ET NOW about the Indian Pharma industry especially with regard to API manufacturing, the Government's PLI scheme and ...
Read more: API is a decadal Opportunity for Indian Pharma Sector: Sudarshan Jain, Apax Partners

Pharma Reviews: Equipping Progress

India's lab equipment market is also going to see a growth spurt as a result of government initiatives to make India ... Fisher Scientific enlightens, “The COVID pandemic has highlighted the critical role of the Indian pharma industry.
Read more: Equipping Progress

US FDA News: Innoveix Pharmaceuticals, Inc. Issues Voluntary Recall of All Sterile Compounded Drug Products Due to A Lack of Sterility Assurance

Innoveix Pharmaceuticals, Inc. is voluntarily recalling the following lots of sterile compounded drug products, within expiry. The products are being recalled due to a lack of assurance of sterility. These concerns arose following a routine inspection of the pharmacy by FDA.

Read more: Innoveix Pharmaceuticals, Inc. Issues Voluntary Recall of All Sterile Compounded Drug Products Due to A Lack of Sterility Assurance

US FDA News: Coronavirus (COVID-19) Update: July 13, 2021

Coronavirus (COVID-19) Update: July 13, 2021
Read more: Coronavirus (COVID-19) Update: July 13, 2021

Pharma Reviews: Cloud adoption: SAP's cloud ERP solution gives Indian firms a digital makeover

“This will enable us to build a strong foundation in India's pharmaceutical industry and support our vision of providing quality, affordable and ...
Read more: Cloud adoption: SAP's cloud ERP solution gives Indian firms a digital makeover

Pharma Reviews: Indian Vaccine Makers Need to be in Regulated Markets to Be 'Legit'

Indian pharma companies lack the patience and investment required to meet global regulatory requirements. Divya Rajagopal. Published: 13 Jul 2021 ...
Read more: Indian Vaccine Makers Need to be in Regulated Markets to Be 'Legit'

Pharma Reviews: Stock Market Live Updates: Sensex up 300 points, Nifty above 15750; banks, financials lead

Shares of FDC Ltd rallied over three percent in early trade on Tuesday after the pharma company announced the launch of India's first oral suspension ...
Read more: Stock Market Live Updates: Sensex up 300 points, Nifty above 15750; banks, financials lead

Pharma Reviews: Nutraceutical Industry: A Consumer Driven Market

India`s nutraceutical industry is predicted to grow to $18 billion by 2025 from ... Data from the Drug Marketing and Manufacturing Association (DMMA) ...
Read more: Nutraceutical Industry: A Consumer Driven Market

Pharma Reviews: Buzzing Stocks: Avenue Supermarts, Granules India, Sandu Pharma and other stocks in news today

Sandu Pharmaceuticals: Porinju Veliyath sold 43,500 equity shares in the company at Rs 51.99 per share on the NSE, the bulk deals data showed.
Read more: Buzzing Stocks: Avenue Supermarts, Granules India, Sandu Pharma and other stocks in news today

Pharma Reviews: Meet Atmanirbhar Indian Brands That Are Paving Way To Make India A Self-reliant Superpower

Representing the company were Dr. Satya Ramani Vadlamani, Chairperson & MD, Murli Krishna Pharma Pvt. Ltd., and Dr. Vijay Shastri, Promoter, ...
Read more: Meet Atmanirbhar Indian Brands That Are Paving Way To Make India A Self-reliant Superpower

Pharma Reviews: ENTOD Pharma plans to expand in medical cosmetics, ophthalmic surgical segments

Mumbai: ENTOD Pharmaceuticals, an Indian international research-based pharmaceutical company with over four decades of pharmaceutical ...
Read more: ENTOD Pharma plans to expand in medical cosmetics, ophthalmic surgical segments

Pharma Reviews: WTO TRIPS Waiver and COVID-19 Vaccine Equity

Second, it will be a boost to India's pharma industry, particularly the generic medicine industry. According to the Biotechnology Innovation Organization, ...
Read more: WTO TRIPS Waiver and COVID-19 Vaccine Equity

Pharma Reviews: Sensex closes 13.50 pts lower, Nifty at 15693; IT, metals drag; realty gains

"Gujarat based Tatva Chintan Pharma has received Sebi's approval for the ₹450 ... They are one of the largest manufacturers of SDAs for zeolites in India. ... “Indian markets started on a positive note following positive Asian market ...
Read more: Sensex closes 13.50 pts lower, Nifty at 15693; IT, metals drag; realty gains

Pharma Reviews: Sustaining Sexual and Reproductive Health Care in a Post-Pandemic World

This includes critical sectors, such as antenatal and post-natal care, and contraceptive services. During the first wave of the COVID-19 pandemic in India, ...
Read more: Sustaining Sexual and Reproductive Health Care in a Post-Pandemic World

Pharma Reviews: An organisation with a diverse talent pool not only makes for good social sense but also makes for ...

Given that I had practically no experience in the pharmaceutical sector and ... do you foresee in Indian pharma, healthcare and life sciences sector?
Read more: An organisation with a diverse talent pool not only makes for good social sense but also makes for ...

Pharma Reviews: Zydus Cadila's Sharvil Patel: We will manufacture one crore doses per month initially

The pharmaceutical giant had recently applied for emergency use authorisation (EUA) with the Indian drug regulator. India has already approved ...
Read more: Zydus Cadila's Sharvil Patel: We will manufacture one crore doses per month initially

Pharma Reviews: Rein in pharma companies, PM Sir!

India has also included Russia's Sputnik and US' Moderna in her vaccine bandwagon. ADVERTISEMENT. Drug firm Zydus Cadilla has now applied for ...
Read more: Rein in pharma companies, PM Sir!

Pharma Reviews: Slashed GST rates on COVID-related items: The stakeholder view

To understand the pharma industry's stakeholders' point of view in this ... Sudarshan Jain, Secretary-General, Indian Pharmaceutical Alliance (IPA) ...
Read more: Slashed GST rates on COVID-related items: The stakeholder view

Pharma Reviews: ICMR to conduct clinical trial for evaluation of Covid-19 therapy with Oxford University

The Indian Council of Medical Research (ICMR) has proposed to conduct a clinical trial for 'randomised evaluation of Covid-19 therapy' along with the ...
Read more: ICMR to conduct clinical trial for evaluation of Covid-19 therapy with Oxford University

US FDA News: Coronavirus (COVID-19) Update: July 9, 2021

Coronavirus (COVID-19) Update: July 9, 2021
Read more: Coronavirus (COVID-19) Update: July 9, 2021

US FDA News: Joint CDC and FDA Statement on Vaccine Boosters

Joint CDC and FDA Statement on Vaccine Boosters
Read more: Joint CDC and FDA Statement on Vaccine Boosters

Pharma Reviews: Replacement in the ranks: Is that what the doctor ordered?

The ministry is in charge of the department of pharmaceuticals that formulates the policies for India's pharma industry. Given his prior experience, can ...
Read more: Replacement in the ranks: Is that what the doctor ordered?

US FDA News: FDA In Brief: FDA Issues Systems Recognition Draft Guidance

This draft guidance explains how the agency plans to adjust its regulatory oversight activities for foods subject to FDA regulatory requirements when the foods are produced in or imported from other countries.
Read more: FDA In Brief: FDA Issues Systems Recognition Draft Guidance

Pharma Reviews: E-pharmacies need an offline-online model for efficient delivery mechanism: Sumit Goel

Sumit Goel: Online pharmacy has evolved over the last couple of years wading through ... Q: Do you expect companies and E-pharmacies to expand their offering through ... DISHA aims to be the Indian counterpart of similar laws.
Read more: E-pharmacies need an offline-online model for efficient delivery mechanism: Sumit Goel

Pharma Reviews: Mankind Pharma gets DRDO nod to manufacture, market COVID drug 2-DG

Alembic Pharmaceuticals gets USFDA nod for anti-depressant drug · Sanofi, GSK receive approval for Phase 3 trial of COVID vaccine in India · Mumbai ...
Read more: Mankind Pharma gets DRDO nod to manufacture, market COVID drug 2-DG

Pharma Reviews: Deaths in Indonesia from Covid-19 raises sharply, numbers doubled in 2 days

... are infected with COVID-19, reducing the medical manpower available to deal with the flow of patients, doctors' associations said, reported WSJ.
Read more: Deaths in Indonesia from Covid-19 raises sharply, numbers doubled in 2 days

Pharma Reviews: Delta can evade antibodies, both vax shots a must: Study

As the healthcare sector across the globe is growing, it has opened great career opportunities to thousands of students of pharmaceutical science ...
Read more: Delta can evade antibodies, both vax shots a must: Study

Pharma Reviews: Breach of IT Rules: Won't protect you, Delhi High Court tells Twitter

... a third party contractor, Sharma sought full compliance with Indian law. ... have ever granted such a leeway to an Indian pharma or an IT company.
Read more: Breach of IT Rules: Won't protect you, Delhi High Court tells Twitter

Pharma Reviews: DBT-NIBMG creates world's first database of genomic variants of oral cancer

In this panel discussion, organized by ETHealthworld.com and BDR Pharma, ... Oral cancer is the most prevalent form of cancer among men in India, ...
Read more: DBT-NIBMG creates world's first database of genomic variants of oral cancer

Pharma Reviews: Sanofi, GSK receive approval for Phase 3 trial of COVID vaccine in India

New Delhi: French pharmaceutical company Sanofi and its British partner GSK (GlaxoSmithKline plc) received approval for their Phase 3 clinical study ...
Read more: Sanofi, GSK receive approval for Phase 3 trial of COVID vaccine in India

US FDA News: Potential Biocompatibility Concerns with NuVasive Specialized Orthopedics’ Precice Devices – Letter to Health Care Providers

Recommendations for Precice devices due to ongoing biocompatibility evaluation.
Read more: Potential Biocompatibility Concerns with NuVasive Specialized Orthopedics’ Precice Devices – Letter to Health Care Providers

Pharma Reviews: Post Covid: Pharmaceutical Industry has become an alluring career option

According to IBEF, Indian pharmaceutical sector supplies over 50% of global demand for various vaccines and also states that India is the largest ...
Read more: Post Covid: Pharmaceutical Industry has become an alluring career option

Pharma Reviews: Sensex closes 486 pts lower, Nifty at 15728; IT in green; metals, banks drag

Zomato to rank among India's top 100 most-valued public companies with its IPO ... Sun Pharma Advanced Research allots warrants worth ₹11.12 bn.
Read more: Sensex closes 486 pts lower, Nifty at 15728; IT in green; metals, banks drag

Pharma Reviews: Live market updates

Indian Furniture Products (FFPL) being a subsidiary of Zuari Global, the ... Mumbai-based pharmaceuticals firm are manufacturers & exporters of foods ...
Read more: Live market updates

Pharma Reviews: Indian Pharma on a Profit Trip(S)

Whether WTO approves India-South Africa proposal for TRIPS waiver or not, Indian industry will remain pivotal to global plans to tackle pandemics.
Read more: Indian Pharma on a Profit Trip(S)

US FDA News: Quidel Recalls Lyra SARS-CoV-2 Assay (M120) Due to Risk of False Negative Results

Quidel is recalling the Lyra SARS-CoV-2 Assay (M120) due to a significant risk of false negative results for patients with high virus amounts
Read more: Quidel Recalls Lyra SARS-CoV-2 Assay (M120) Due to Risk of False Negative Results

Pharma Reviews: Making socially affordable drug market, StayHappi Pharmacy takes on growth of Pharma Industry

New Delhi [India], July 7 (ANI/The PRTree): The growth and structure of the pharmaceutical industry have an impact on healthcare expenditure.
Read more: Making socially affordable drug market, StayHappi Pharmacy takes on growth of Pharma Industry

Pharma Reviews: India expects 3-4 mln Pfizer, Moderna vaccine doses through COVAX by August: Sources

Apart from Moderna and Pfizer, India has also been courting Johnson & Johnson for vaccine supplies. J&J has already signed a manufacturing ...
Read more: India expects 3-4 mln Pfizer, Moderna vaccine doses through COVAX by August: Sources

Pharma Reviews: Sensex closes 194 points higher, Nifty at 15880; metals, realty top gainers

The Indian IT industry will stage a “strong recovery" in 2021-22 with a ... Natco Pharma Ltd's stock was at ₹1,156.00, down 0.76% at 12:24 pm.
Read more: Sensex closes 194 points higher, Nifty at 15880; metals, realty top gainers

Pharma Reviews: Lenders in talks with India's vaccine makers to expand capacity

The meeting was attended by executives from companies such as Serum Institute of India, Bharat Biotech, Gennova, Zydus Cadila, Aurobindo Pharma ...
Read more: Lenders in talks with India's vaccine makers to expand capacity

US FDA News: Coronavirus (COVID-19) Update: July 6, 2021

Coronavirus (COVID-19) Update: July 6, 2021
Read more: Coronavirus (COVID-19) Update: July 6, 2021

Pharma Reviews: Stock Market Highlights: Sensex, Nifty end marginally lower dragged by auto, IT, PSU banks

... Market Highlights: Indian equity indices, Sensex and Nifty erased day's gains to end marginally lower Tuesday dragged by selling in auto, pharma, ...
Read more: Stock Market Highlights: Sensex, Nifty end marginally lower dragged by auto, IT, PSU banks

Pharma Reviews: Cipla may be Re-Rated for Probable Commercial JV with Moderna'mRNA COVID Vaccine

Cipla is a major Indian pharmaceutical company and MNC; almost 60% of its ... as the COVID-19 vaccines, mRNA could transform the drug industry.
Read more: Cipla may be Re-Rated for Probable Commercial JV with Moderna'mRNA COVID Vaccine

Pharma Reviews: Here's all that is required for rebuilding healthcare in India

Indian healthcare is at the influx of inventions and innovations. There's a ... Whether it is automation of drug manufacturing processes, or ramping up of ...
Read more: Here's all that is required for rebuilding healthcare in India

Pharma Reviews: Market LIVE Update: Sensex, Nifty up 0.56%; Jun services PMI shrinks; IT in red

Indian indices gained over 0.66% on Monday. ... IT, pharma drag ... One97 Communications Ltd, the parent of Indian payments firm Paytm, will file a ...
Read more: Market LIVE Update: Sensex, Nifty up 0.56%; Jun services PMI shrinks; IT in red

Pharma Reviews: Market LIVE Updates: Indices trade higher, Nifty around 15800; Asia dips on China tech worries

Panacea Biotec share price rose 9 percent on July 5 after company received manufacturing license from Drugs Controller General (India) (DCGI) for ...
Read more: Market LIVE Updates: Indices trade higher, Nifty around 15800; Asia dips on China tech worries

Pharma Reviews: Panache Digilife to make laptops under PLI scheme, target WfH

Mumbai-based up-and-coming IT hardware manufacturer Panache Digilife said it ... While India still has some manufacturing industries left, many of India's ... after Natco Pharma sought a compulsory license from government of India ...
Read more: Panache Digilife to make laptops under PLI scheme, target WfH

Pharma Reviews: Movers & Shakers | Top 10 stocks that moved the most last week

Experts see the Indian market continuing its strong momentum given the ... The Indian pharma industry could be worth $130 billion by 2030, says ...
Read more: Movers & Shakers | Top 10 stocks that moved the most last week

Pharma Reviews: Pharma PLI scheme to reduce India's dependence on API imports: Report

India's production-linked incentive (PLI) scheme will reduce India's dependence on imports for key active pharmaceutical ingredients (APIs) said India ...
Read more: Pharma PLI scheme to reduce India's dependence on API imports: Report

Pharma Reviews: 'Nifty Pharma can hit 15700 by June 2022'

The Indian pharma industry could be worth $130 billion by 2030, says Gaurav Garg of CapitalVia Global Research. Gaurav Garg. July 04, 2021 / 12:39 ...
Read more: 'Nifty Pharma can hit 15700 by June 2022'

Pharma Reviews: Pharma PLI scheme to reduce India's dependence on API imports: Report

New Delhi: India's production-linked incentive (PLI) scheme will reduce India's dependence on imports for key active pharmaceutical ingredients ...
Read more: Pharma PLI scheme to reduce India's dependence on API imports: Report

Pharma Reviews: Stock market as a mirror — how Indian biz has changed in 40 years, and what it's missing

Of 50 stocks in Nifty 50, 11 are of firms in financial services, 6 in auto, 5 in IT services, 4 in pharma. Manufacturing has poor representation outside auto.
Read more: Stock market as a mirror — how Indian biz has changed in 40 years, and what it's missing

Pharma Reviews: 9 from UP held for 'supplying' chalk powder instead of paracetamol to Daman pharma firm

Daman and DN&H Health Director V K Das told The Indian Express, “The pharma company had, through India mart, placed an order for paracetamol ...
Read more: 9 from UP held for 'supplying' chalk powder instead of paracetamol to Daman pharma firm

Pharma Reviews: Stock Market Highlights: Sensex rises 166 points, Nifty ends above 15700 led by pharma stocks ...

Stock Market Highlights: Indian equity indices, Sensex and Nifty ended higher amid volatility Friday led by gains in pharma and realty stocks. Broader ...
Read more: Stock Market Highlights: Sensex rises 166 points, Nifty ends above 15700 led by pharma stocks ...

Pharma Reviews: Congress says, why Centre 'conspicuously silent' on Covaxin pricing controversy in Brazil

The Congress leader said this issue brings disrepute and taint to the entire Indian pharma industry which is a pride to the country. She said that the ...
Read more: Congress says, why Centre 'conspicuously silent' on Covaxin pricing controversy in Brazil

US FDA News: Coronavirus (COVID-19) Update: July 2, 2021

Coronavirus (COVID-19) Update
Read more: Coronavirus (COVID-19) Update: July 2, 2021

US FDA News: Medtronic Vascular Recalls Angiographic Guidewire Component Due to Being Non-sterile

Angiographic Guidewire Component is a guidewire to help place catheters into the vasculature.
Read more: Medtronic Vascular Recalls Angiographic Guidewire Component Due to Being Non-sterile

Pharma Reviews: Minimal impact of Covid 2.0 on the Indian pharma industry; ICRA estimates FY22 growth at 7-9%

The impact of Covid-19 on the Indian pharmaceutical companies was relatively limited in FY2021 owing to the inelastic demand for pharmaceutical ...
Read more: Minimal impact of Covid 2.0 on the Indian pharma industry; ICRA estimates FY22 growth at 7-9%

Pharma Reviews: Top Pharma Mutual Funds To Start SIP In India 2021 For Long Term Capital Appreciation

As per the India Brand Equity Foundation, Indian pharma industry ranks third for pharma production by volume worldwide. The recent government ...
Read more: Top Pharma Mutual Funds To Start SIP In India 2021 For Long Term Capital Appreciation